PF-07275315
Sponsors
Pfizer Inc., Pfizer
Conditions
AsthmaAtopic DermatitisHealthyHealthy VolunteersMODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase 1
A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People
CompletedNCT05411588
Start: 2022-06-09End: 2024-05-13Updated: 2025-05-25
A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants
CompletedNCT06675188
Start: 2025-01-06End: 2025-07-14Updated: 2025-08-03
Phase 2
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingNCT05995964
Start: 2023-08-22End: 2027-03-08Target: 340Updated: 2026-05-04
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
RecruitingNCT06977581
Start: 2025-05-20End: 2027-05-31Target: 252Updated: 2026-05-04
C4531031 - AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Not yet recruitingCTIS2024-518587-12-00
Target: 90Updated: 2026-06-10